Review of Potential Diagnostic and Therapeutic Developments in Systemic Lupus Erythematosus (SLE) - PubMed
6 hours ago
- #SLE
- #Treatment
- #Biomarkers
- SLE is a complex autoimmune disease affecting multiple organs, with challenges in diagnosis and treatment.
- Autoantibodies and immune complexes contribute to vasculature accumulation and organ damage in SLE.
- Recent research highlights promising biomarkers like PTX3 and S100A8 for early diagnosis and activity correlation.
- Monoclonal antibodies such as belimumab and anifrolumab are FDA-approved treatments, with others in Phase II trials.
- Advances in biomarkers and biologics aim to enable personalized, targeted therapy for improved SLE management.